Global Initiative Orders 120 Million Abbott, SD Biosensor COVID-19 Rapid Antigen Tests

Tests will be priced at under $5 each for low- and middle-income countries.

Coronavirus

A set of agreements to make COVID-19 antigen rapid tests available to low- and middle-income countries was announced on 28 September by the Access to COVID-19 Tools (ACT) Accelerator, a global collaboration initiative launched earlier this year by groups including the World Health Organization (WHO).

The ACT Accelerator will initially make available 120 million tests under its remit to foster the development of COVID-19 vaccines,...

More from In Vitro Diagnostics

More from Diagnostics

Medtronic’s ‘Strategic Expansion’ Into Remote Monitoring

 

“The Corsano wearable strengthens Medtronic’s acute care and monitoring portfolio,” Marc De Martini, vice president at Medtronic, told Medtech Insight.

No Strings Attached: Big Players Chase Insulet In Fast-Growing Tubeless Insulin Pump Market

 
• By 

Medtronic, Tandem and Beta Bionics are gearing up to bring tubeless patch pumps to market, chasing Insulet’s Omnipod 5, the only FDA-cleared patch pump for type 1 and type 2 diabetes. Analysts expect tubeless models to eventually displace durable pumps.

Surgical Robotics CEOs Talk Metrics For Success, Valuations, Competition And IPO Outlook

 
• By 

Leaders of robotic systems companies Distalmotion, Neocis and Noah Medical discussed success metrics, competition and funding. Institutional investors are focusing on utilization, procedure rates and a clear path to profitability as the IPO window reopens, BTIG analyst Ryan Zimmerman said.